EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multitargeted protein degradation: Integrating small-molecule, biomacromolecular, and nano-PROTACs for paradigm shifts in drug discovery

Jinghua Yang, Yujing Zhang, Miao Zhang, Dongming Xing, Chao Wang

Materials Today Advances · 2025-12 · 28 · 100644

DOI: 10.1016/j.mtadv.2025.100644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Today Advances, 2025-12. Verfasst von Jinghua Yang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Qingdao Postdoctoral Science Foundation, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) have revolutionized drug discovery by enabling targeted protein degradation via the ubiquitin-proteasome system (UPS), overcoming limitations of traditional occupancy-based inhibitors. This innovative approach has expanded the therapeutic landscape, particularly for previously “undruggable” targets. Recent advances have led to the emergence of dual/multi-target PROTACs, which simultaneously degrade multiple disease-associated proteins, offering a novel strategy to tackle complex pathologies driven by interconnected molecular networks. Such multi-targeting is especially relevant in multifactorial diseases, including cancer and neurodegenerative disorders, where single-target inhibition often proves insufficient. This review comprehensively examines the latest advancements in dual-target/multi-target PROTACs, including small-molecule PROTACs, biomacromolecule PROTACs, and nano-PROTACs, with a particular focus on the design principles, mechanism insights, and therapeutic potential in various diseases. Furthermore, we critically evaluate existing challenges-such as selectivity, pharmacokinetic optimization, and resistance mechanisms-and discuss future perspectives to maximize their clinical impact in precision medicine.

Förderung

  • National Natural Science Foundation of China
  • Qingdao Postdoctoral Science Foundation
  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, J., Zhang, Y., Zhang, M., Xing, D., & Wang, C. (2025). Multitargeted protein degradation: Integrating small-molecule, biomacromolecular, and nano-PROTACs for paradigm shifts in drug discovery. Materials Today Advances, 28, 100644. https://doi.org/10.1016/j.mtadv.2025.100644

Vancouver

Yang J, Zhang Y, Zhang M, Xing D, Wang C. Multitargeted protein degradation: Integrating small-molecule, biomacromolecular, and nano-PROTACs for paradigm shifts in drug discovery. Materials Today Advances. 2025;28:100644. doi:10.1016/j.mtadv.2025.100644

BibTeX
@article{Yang2025,
  author = {Yang, Jinghua and Zhang, Yujing and Zhang, Miao and Xing, Dongming and Wang, Chao},
  title = {Multitargeted protein degradation: Integrating small-molecule, biomacromolecular, and nano-PROTACs for paradigm shifts in drug discovery},
  journal = {Materials Today Advances},
  year = {2025},
  volume = {28},
  pages = {100644},
  doi = {10.1016/j.mtadv.2025.100644}
}
Kostenlos starten →